Sanofi says back on track to regain solid position in cancer drugs

PARIS (Reuters) - Sanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market in the coming years on the back of its immunotherapy drugs and efforts in new areas such as molecular oncology.